Literature DB >> 31292489

Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells.

Tomoyuki Ohsugi1, Kiyoshi Yamaguchi1, Chi Zhu1, Tsuneo Ikenoue1, Kiyoko Takane1, Masaru Shinozaki2, Giichiro Tsurita2, Hideaki Yano3, Yoichi Furukawa4.   

Abstract

Impaired Wnt signaling pathway plays a crucial role in the development of colorectal cancer through activation of the β-catenin/TCF7L2 complex. Although genes upregulated by Wnt/β-catenin signaling have been intensively studied, the roles of downregulated genes are poorly understood. Previously, we reported that interferon-induced proteins with tetratricopeptide repeats 2 (IFIT2) was downregulated by the Wnt/β-catenin signaling, and that the suppressed expression of IFIT2 conferred antiapoptotic property to colorectal cancer (CRC) cells. However, the mechanisms underlying how Wnt/β-catenin signaling regulates IFIT2 remain to be elucidated. In this study, we have uncovered that the expression of IFIT2 is induced by IRF1, which is negatively regulated by the Wnt/β-catenin signaling. In addition, we found that downregulation of IRF1 is mediated by its degradation through the ubiquitination-proteasome pathway, and that decreased activity of a deubiquitinase complex containing USP1 and UAF1 is involved in the degradation of IRF1 by Wnt/β-catenin signaling. These data should provide better understanding of the Wnt signaling pathway and human carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31292489     DOI: 10.1038/s41388-019-0856-9

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  69 in total

1.  The ubiquitin-specific protease 12 (USP12) is a negative regulator of notch signaling acting on notch receptor trafficking toward degradation.

Authors:  Julien Moretti; Patricia Chastagner; Chih-Chao Liang; Martin A Cohn; Alain Israël; Christel Brou
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

Review 2.  Dysregulation of growth factor signaling in human hepatocellular carcinoma.

Authors:  K Breuhahn; T Longerich; P Schirmacher
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

3.  UAF1 is a subunit of multiple deubiquitinating enzyme complexes.

Authors:  Martin A Cohn; Younghoon Kee; Wilhelm Haas; Steven P Gygi; Alan D D'Andrea
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

4.  IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes.

Authors:  A Kano; T Haruyama; T Akaike; Y Watanabe
Journal:  Biochem Biophys Res Commun       Date:  1999-04-21       Impact factor: 3.575

5.  Structural Insights into WD-Repeat 48 Activation of Ubiquitin-Specific Protease 46.

Authors:  Jianping Yin; Allyn J Schoeffler; Katherine Wickliffe; Kim Newton; Melissa A Starovasnik; Erin C Dueber; Seth F Harris
Journal:  Structure       Date:  2015-09-17       Impact factor: 5.006

6.  Regulation of monoubiquitinated PCNA by DUB autocleavage.

Authors:  Tony T Huang; Sebastian M B Nijman; Kanchan D Mirchandani; Paul J Galardy; Martin A Cohn; Wilhelm Haas; Steven P Gygi; Hidde L Ploegh; René Bernards; Alan D D'Andrea
Journal:  Nat Cell Biol       Date:  2006-03-12       Impact factor: 28.824

7.  A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway.

Authors:  Martin A Cohn; Przemyslaw Kowal; Kailin Yang; Wilhelm Haas; Tony T Huang; Steven P Gygi; Alan D D'Andrea
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

8.  The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.

Authors:  X Li; P D Stevens; H Yang; P Gulhati; W Wang; B M Evers; T Gao
Journal:  Oncogene       Date:  2012-03-05       Impact factor: 9.867

9.  Screening of DUB activity and specificity by MALDI-TOF mass spectrometry.

Authors:  Maria Stella Ritorto; Richard Ewan; Ana B Perez-Oliva; Axel Knebel; Sara J Buhrlage; Melanie Wightman; Sharon M Kelly; Nicola T Wood; Satpal Virdee; Nathanael S Gray; Nicholas A Morrice; Dario R Alessi; Matthias Trost
Journal:  Nat Commun       Date:  2014-08-27       Impact factor: 14.919

10.  The IRF family of transcription factors: Inception, impact and implications in oncogenesis.

Authors:  Hideyuki Yanai; Hideo Negishi; Tadatsugu Taniguchi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more
  6 in total

1.  Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization.

Authors:  Jin-Tao Li; Kai-Yue Li; Ying Su; Yuan Shen; Ming-Zhu Lei; Fan Zhang; Miao Yin; Zheng-Jun Chen; Wen-Yu Wen; Wei-Guo Hu; Dan Su; Jia Qu; Qun-Ying Lei
Journal:  Natl Sci Rev       Date:  2021-11-26       Impact factor: 23.178

2.  Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).

Authors:  Yihe Yan; Leting Zheng; Qiang Du; Hamza Yazdani; Kun Dong; Yarong Guo; David A Geller
Journal:  Cancer Lett       Date:  2021-03-06       Impact factor: 9.756

3.  Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).

Authors:  Yong Ji; Jian Lv; Di Sun; Yufeng Huang
Journal:  Int J Mol Med       Date:  2021-10-29       Impact factor: 4.101

4.  HDAC8 Promotes Liver Metastasis of Colorectal Cancer via Inhibition of IRF1 and Upregulation of SUCNR1.

Authors:  Jierong Chen; Lixue Cao; Jianhong Ma; Caifeng Yue; Dandan Zhu; Ran An; Xiaoxiao Wang; Yunmiao Guo; Bing Gu
Journal:  Oxid Med Cell Longev       Date:  2022-08-16       Impact factor: 7.310

5.  Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.

Authors:  Deyao Shi; Shidai Mu; Feifei Pu; Binlong Zhong; Binwu Hu; Jianxiang Liu; Tongchuan He; Zhicai Zhang; Zengwu Shao
Journal:  Front Cell Dev Biol       Date:  2021-07-01

6.  FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State.

Authors:  Athanasios Blanas; Anouk Zaal; Irene van der Haar Àvila; Maxime Kempers; Laura Kruijssen; Mike de Kok; Marko A Popovic; Joost C van der Horst; Sandra J van Vliet
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.